MarketInOut Stock Screener Log In | Sign Up
 

BioMarin Pharmaceutical Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 06/09/2026 13:18
BioMarin Pharmaceutical Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization10,973 mln
Float192 mln
Earnings Date08/04/2026

EPS

1.39
Stretched

P / E

41.30
High premium

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.8
Likely reliable

1-Year Forecast

87.85
Exceptional upside

Relative Strength

93 / 100
Top performer

Business Description

BioMarin is a California-based biotechnology company founded in 1996 that creates and sells treatments for rare, life-threatening diseases across markets in the US, Europe, Latin America, the Middle East, Asia Pacific, and beyond. Its portfolio includes several approved medicines targeting conditions such as certain bone growth disorders, inherited metabolic diseases, and enzyme deficiencies, along with a pipeline of new treatments in development. The company sells its products through specialty pharmacies, hospitals, distributors, and government agencies worldwide.

Key Fundamentals

EPS1.39
P/E41.30
ROE4.45
RPS16.50
ROIC3.95
ROA3.50
Interest Cover13.71
EBITDA, mln482
EV / EBITDA19.45
EV / EBIT22.97
Revenue, mln3,242
EV / Revenue2.89

Financial Strength

Altman Z-Score3.69
Piotroski F-Score 5 / 9
Beneish M-Score-2.8
Price to Intrinsic Value1.41
Price to Lynch Fair Value0.89
Price to Graham Number1.36
1-Year Target Price87.85
Short Ratio6.37
Short % of Float5.89

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 7.67% 95 / 100   
1 Month 6.2% 87 / 100   
2 Months -1.91% 37 / 100   
6 Months 7.51% 67 / 100   
1 Year 1.34% 36 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us